Search hospitals > North Dakota > Fargo

Sanford Broadway Medical Center

Claim this profile
Fargo, North Dakota 58102
Global Leader in Parotid Gland Cancer
Global Leader in Cancer
Conducts research for Breast Cancer
Conducts research for Lung Cancer
Conducts research for Relapse
421 reported clinical trials
4 medical researchers
Photo of Sanford Broadway Medical Center in FargoPhoto of Sanford Broadway Medical Center in FargoPhoto of Sanford Broadway Medical Center in Fargo

Summary

Sanford Broadway Medical Center is a medical facility located in Fargo, North Dakota. This center is recognized for care of Parotid Gland Cancer, Cancer, Breast Cancer, Lung Cancer, Relapse and other specialties. Sanford Broadway Medical Center is involved with conducting 421 clinical trials across 590 conditions. There are 4 research doctors associated with this hospital, such as Preston D. Steen, Daniel Almquist, Samuel Milanovich, MD, and Maria Bell, MD.

Area of expertise

1Parotid Gland Cancer
Global Leader
Sanford Broadway Medical Center has run 111 trials for Parotid Gland Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II
2Cancer
Global Leader
Sanford Broadway Medical Center has run 81 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage I
Stage II

Top PIs

Clinical Trials running at Sanford Broadway Medical Center

Lung Cancer
Breast Cancer
Parotid Gland Cancer
Cancer
Breast cancer
Non-Small Cell Lung Cancer
Squamous Cell Carcinoma
Oropharyngeal Carcinoma
Skin Cancer
Kidney Cancer
Image of trial facility.

Chemotherapy + Immunotherapy vs. Immunotherapy

for Advanced Lung Cancer

This phase III trial compares the effect of adding chemotherapy to immunotherapy (pembrolizumab) versus immunotherapy alone in treating patients with stage IIIB-IV lung cancer. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab and chemotherapy may help stabilize lung cancer.
Recruiting2 awards Phase 3
Image of trial facility.

Treatment Timing

for Non-Small Cell Lung Cancer

This phase III trial compares standard therapy given after surgery (adjuvant) to standard therapy given before and after surgery (perioperative) in treating patients with stage II-IIIB non-small cell lung cancer (NSCLC) that can be removed by surgery (resectable). The usual approach for patients with resectable NSCLC is chemotherapy and/or immunotherapy before surgery, after surgery, or both before and after surgery. This study is being done to find out which approach is better at treating patients with lung cancer. Treatment will be administered according to the current standard of care at the time of enrollment. Chemotherapy options may include cisplatin, carboplatin, pemetrexed, gemcitabine, docetaxel, and vinorelbine at standard doses according to the treating physician. Cisplatin is in a class of medications known as platinum-containing compounds. It works by killing, stopping or slowing the growth of tumor cells. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of tumor cells. Pemetrexed is in a class of medications called antifolate antineoplastic agents. It works by stopping cells from using folic acid to make deoxyribonucleic acid (DNA) and may kill tumor cells. Gemcitabine is a chemotherapy drug that blocks the cells from making DNA and may kill tumor cells. Docetaxel is in a class of medications called taxanes. It stops tumor cells from growing and dividing and may kill them. Other chemotherapy drugs, such as vinorelbine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading . Immunotherapy with monoclonal antibodies, such as nivolumab, pembrolizumab, and atezolizumab, may help the body's immune system attack the tumor, and may interfere with the ability of tumor cells to grow and spread. Starting treatment with chemotherapy and immunotherapy prior to surgery and continuing treatment after surgery may be a more effective treatment option than adjuvant therapy alone in patients with stage II-IIIB resectable NSCLC.
Recruiting2 awards Phase 34 criteria
Image of trial facility.

Crizotinib

for Non-Small Cell Lung Cancer

This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Sanford Broadway Medical Center?
Sanford Broadway Medical Center is a medical facility located in Fargo, North Dakota. This center is recognized for care of Parotid Gland Cancer, Cancer, Breast Cancer, Lung Cancer, Relapse and other specialties. Sanford Broadway Medical Center is involved with conducting 421 clinical trials across 590 conditions. There are 4 research doctors associated with this hospital, such as Preston D. Steen, Daniel Almquist, Samuel Milanovich, MD, and Maria Bell, MD.
Where is Sanford Broadway Medical Center located?
**Sanford Broadway Medical Center** - **Location:** 801 N Broadway, Fargo, ND 58102 - **Type:** Short Term Acute Care Hospital - **Staffed Beds:** 533 - **Clinical Services:** Cardiovascular, Emergency, Neurosciences, Oncology, Orthopedic, Psychiatry, Pulmonology, Surgery, Urology, Vascular Surgery
Who should I call to ask about financial aid or insurance network?
For financial assistance at Sanford Broadway Medical Center: - Apply online via MyHealth account or download the application from their website. - For further assistance, contact customer service at 844-498-2900. - For insurance inquiries, reach out to Sanford Health Plan's customer service at (800) 752-5863 or email memberservices@sanfordhealth.org.
What insurance does Sanford Broadway Medical Center accept?
Sanford Broadway Medical Center accepts various insurance plans, including GEHA, Health First Health Plan, Health Scope, and Humana Commercial, National POS - Open Access. It does not accept plans such as Aetna Whole Health Plan, Aetna Medicare Select HMO, and others listed. For current insurance policies and to understand your behavioral health insurance benefits, contact them at (877) 629-2999.
What awards or recognition has Sanford Broadway Medical Center received?
Sanford Broadway Medical Center, located in Fargo, North Dakota, has been honored as a 2023 Rising Star by Vizient, Inc. for its significant improvements in care quality, placing in the top quartile of the Vizient Quality and Accountability Ranking. The hospital is also recognized by the American Heart Association for its dedication to enhancing outcomes for patients with heart disease and stroke.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security